GH Research to Host Investor Meetings at J.P. Morgan Healthcare Conference

Ticker: GHRS · Form: 6-K · Filed: Jan 5, 2024 · CIK: 1855129

Complexity: simple

Sentiment: neutral

Topics: investor-relations, conference, corporate-presentation

TL;DR

**GH Research is meeting investors at J.P. Morgan, watch for updates!**

AI Summary

GH Research PLC announced on January 5, 2024, that it will be holding one-on-one investor meetings at the 42nd Annual J.P. Morgan Healthcare Conference from January 8-11, 2024, in San Francisco. The company also released an updated investor presentation on its website, attached as Exhibit 99.1. This matters to investors because these meetings and the updated presentation could provide new insights into the company's strategy and pipeline, potentially influencing stock performance.

Why It Matters

Investor meetings at major conferences like J.P. Morgan can generate significant interest and provide clarity on a company's future, potentially impacting its stock price.

Risk Assessment

Risk Level: low — This filing is primarily an informational update about upcoming investor relations activities and does not contain inherently risky financial or operational news.

Analyst Insight

A smart investor would review the updated investor presentation (Exhibit 99.1) to understand any new information or strategic shifts GH Research PLC might be highlighting to potential investors at the J.P. Morgan conference.

Key Players & Entities

Forward-Looking Statements

FAQ

What is the primary purpose of this 6-K filing by GH Research PLC?

The primary purpose of this 6-K filing is to inform investors that GH Research PLC will be holding one-on-one investor meetings at the 42nd Annual J.P. Morgan Healthcare Conference from January 8-11, 2024, and that an updated investor presentation was made available on January 5, 2024.

When and where is the J.P. Morgan Healthcare Conference taking place?

The 42nd Annual J.P. Morgan Healthcare Conference is scheduled to take place from January 8-11, 2024, in San Francisco, California.

What specific document was attached as an exhibit to this 6-K filing?

Exhibit 99.1, titled 'Corporate Presentation for January 2024,' was attached to this 6-K filing.

Who signed this 6-K report on behalf of GH Research PLC and what is their title?

The 6-K report was signed by Julie Ryan, who holds the title of Vice President, Finance for GH Research PLC.

Does GH Research PLC commit to updating the investor presentation in the future?

No, the filing explicitly states that the information in the presentation is provided as of January 5, 2024, and the Company does not undertake any obligation to update the presentation in the future or to update forward-looking statements to reflect subsequent actual results.

Filing Stats: 290 words · 1 min read · ~1 pages · Grade level 12.3 · Accepted 2024-01-05 07:30:14

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January, 2024. Commission File Number: 001-40530 GH Research PLC (Exact name of registrant as specified in its charter) Joshua Dawson House Dawson Street Dublin 2 D02 RY95 Ireland (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F Form 40-F INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K GH Research PLC (the "Company") will hold one-on-one investor meetings during the 42 nd Annual J.P. Morgan Healthcare Conference, which is scheduled to take place from January 8-11, 2024, in San Francisco, California. On January 5, 2024, the Company made available an updated investor presentation on its website. A copy of the investor presentation is attached hereto as Exhibit 99.1. The fact that this presentation is being made available and furnished herewith should not be deemed an admission as to the materiality of any information contained in the materials. The information contained in the presentation is being provided as of January 5, 2024, and the Company does not undertake any obligation to update the presentation in the future or to update forward-looking statements to reflect subsequent actual results. 1 EXHIBIT INDEX Exhibit No. Description 99.1 Corporate Presentation for January 2024 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GH Research PLC Date: January 5, 2024 By: /s/ Julie Ryan Name: Julie Ryan Title: Vice President, Finance 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing